Spectrum Pharmaceuticals
Spectrum Pharmaceuticals, Inc.
1500 S. Eastern Avenue #240
Henderson, NV 89052
Phone: (702) 835-6300Website: https://www.sppirx.com/Careers: www.sppirx.com/800-careers.html
Latest news
- Spectrum Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for Poziotinib
25 November 2022 - Spectrum Pharmaceuticals Provides Update on Poziotinib Following FDA Oncologic Drugs Advisory Committee Meeting
22 September 2022 - FDA Approves Rolvedon (eflapegrastim-xnst) Injection to Decrease the Incidence of Chemotherapy-Induced Neutropenia
9 September 2022 - Spectrum Pharmaceuticals Announces Acceptance of New Drug Application Filing for Poziotinib
11 February 2022 - Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib
6 December 2021 - Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for Rolontis (eflapegrastim)
6 August 2021 - FDA Grants Fast Track Designation to Spectrum Pharmaceuticals’ Poziotinib
11 March 2021 - Spectrum Pharmaceuticals Announces Submission of Biologics License Application to the FDA for Rolontis (eflapegrastim) as a Treatment for Chemotherapy-Induced Neutropenia
27 December 2018 - Spectrum Pharmaceuticals Receives FDA Approval of Khapzory (levoleucovorin) for Injection
23 October 2018 - Spectrum Pharmaceuticals Announces Release of Updated Poziotinib Data From MD Anderson Phase 2 Study in Non-Small Cell Lung Cancer Patients
24 September 2018
Drugs Associated with Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals, Inc. manufactures, markets and/or distributes more than 8 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
Brand/Generic Name | Reviews | Rating |
---|---|---|
Beleodaq
Generic name: belinostat Drug class: histone deacetylase inhibitors |
||
Evomela
Generic name: melphalan Drug class: alkylating agents |
||
Folotyn
Generic name: pralatrexate Drug class: antimetabolites |
1 review | 1.0 / 10 |
Fusilev
Generic name: levoleucovorin Drug class: antidotes |
||
Khapzory
Generic name: levoleucovorin Drug class: antidotes |
||
Marqibo
Generic name: vincristine liposome Drug class: mitotic inhibitors |
||
Rolvedon
Generic name: eflapegrastim Drug class: colony stimulating factors |
1 review | 1.0 / 10 |
Zevalin
Generic name: ibritumomab Drug class: CD20 monoclonal antibodies, radiologic conjugating agents |
||
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). |